Madrigal Pharmaceuticals, Inc. MDGL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $232.19M+13.9% | $203.78M-32.2% | $300.69M+57.3% | $191.19M+1.4% | $188.65M+79.6% | ||
| $585.74M-25.4% | $784.87M-3.6% | $814.06M+33.3% | $610.83M-7.4% | $659.42M-20.2% | ||
| $5.16M+1.3% | $5.09M+1.8% | $5M0.0% | $5M0.0% | $5M0.0% | ||
| $187.36M+39.3% | $134.48M+18.7% | $113.29M+43.0% | $79.23M+29.0% | $61.43M+14.1% | ||
| $112.07M+49.7% | $74.84M+8.0% | $69.32M+9.2% | $63.5M+14.9% | $55.24M+62.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $106.26M+57.1% | $67.63M+7.5% | $62.9M+8.6% | $57.91M+13.6% | $50.97M+72.6% | ||
| $5.81M-19.4% | $7.21M+12.4% | $6.41M+14.8% | $5.59M+30.8% | $4.27M-5.8% | ||
| $64.96M+35.9% | $47.8M-3.1% | $49.33M-15.8% | $58.6M+152% | $23.24M+68.6% | ||
| $1.18B-5.1% | $1.25B-7.5% | $1.35B+34.2% | $1B+1.6% | $987.98M-4.4% | ||
| $8.04M+436% | $1.5M-48.5% | $2.91M+80.4% | $1.62M-15.0% | $1.9M-13.2% | ||
| $6.2M+25.6% | $4.94M-8.3% | $5.39M-8.1% | $5.86M+178% | $2.11M-12.1% | ||
| $7.28M-1.3% | $7.38M-1.3% | $7.48M+64.4% | $4.55M-2.0% | $4.64M-1.9% | ||
| $23.5M— | $0— | —— | —— | —— | ||
| $1.23B-2.6% | $1.26B-7.6% | $1.36B+34.2% | $1.02B+1.9% | $996.63M-4.4% | ||
| $60.8M+24.4% | $48.88M+8.8% | $44.94M+18.3% | $37.98M-9.7% | $42.06M-3.5% | ||
| $34.33M-50.4% | $69.21M+35.4% | $51.11M+84.6% | $27.69M+51.5% | $18.27M-85.3% | ||
| $29.98M— | —— | $31.06M+168% | $11.6M0.0% | $11.6M— | ||
| $1.7M+66.7% | $1.02M-6.0% | $1.08M+3.2% | $1.05M+3.2% | $1.02M+3.4% | ||
| $128.89M— | —— | $148.98M+569% | $22.28M— | —— | ||
| $338.26M+9.0% | $310.29M-20.7% | $391.41M+99.2% | $196.5M+17.5% | $167.24M-1.2% | ||
| $340.33M+0.1% | $339.88M0.0% | $339.75M+187% | $118.38M+0.3% | $118.01M+0.4% | ||
| $5.28M-21.5% | $6.73M+20.9% | $5.57M+23.0% | $4.52M+503% | $750K-26.3% | ||
| $345.61M-0.3% | $346.61M+0.4% | $345.32M+181% | $122.9M+3.5% | $118.76M+0.1% | ||
| $683.87M+4.1% | $656.9M-10.8% | $736.73M+131% | $319.4M+11.7% | $285.99M-0.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+9,999,900% | ||
| $2.73B+1.3% | $2.69B+1.3% | $2.66B+1.7% | $2.61B+1.0% | $2.59B+1.2% | ||
| -$2.18B-4.5% | -$2.09B-2.9% | -$2.03B-6.0% | -$1.92B-2.3% | -$1.88B-4.1% | ||
| $1.08M+23.9% | $873K-18.3% | $1.07M-3.9% | $1.11M+186% | $389K-16.9% | ||
| $543.45M-9.8% | $602.69M-3.7% | $625.73M-10.1% | $695.98M-2.1% | $710.64M-5.8% | ||
| $1.23B-2.6% | $1.26B-7.6% | $1.36B+34.2% | $1.02B+1.9% | $996.63M-4.4% | ||
| $0— | $0— | —— | —— | —— | ||
| $0— | $0— | —— | —— | —— | ||
| $585.74M-25.4% | $784.87M-3.6% | $814.06M+33.3% | $610.83M-7.4% | $659.42M-20.2% | ||
| $5.81M-19.4% | $7.21M+12.4% | $6.41M+14.8% | $5.59M+30.8% | $4.27M-5.8% | ||
| $23.5M— | $0— | —— | —— | —— | ||
| $6.2M+25.6% | $4.94M-8.3% | $5.39M-8.1% | $5.86M+178% | $2.11M-12.1% | ||
| $7.28M-1.3% | $7.38M-1.3% | $7.48M+64.4% | $4.55M-2.0% | $4.64M-1.9% | ||
| $6.2M+25.6% | $4.94M-8.3% | $5.39M-8.1% | $5.86M+178% | $2.11M-12.1% | ||
| $23.5M— | $0— | —— | —— | —— | ||
| $6.2M+25.6% | $4.94M-8.3% | $5.39M-8.1% | $5.86M+178% | $2.11M-12.1% | ||
| $23.5M— | $0— | —— | —— | —— | ||
| $34.33M-50.4% | $69.21M+35.4% | $51.11M+84.6% | $27.69M+51.5% | $18.27M-47.7% | ||
| $275.76M+5.9% | $260.39M-24.6% | $345.38M+119% | $157.48M+26.8% | $124.17M-0.4% | ||
| $275.76M+5.9% | $260.39M-24.6% | $345.38M+119% | $157.48M+26.8% | $124.17M-0.4% | ||
| $34.33M-50.4% | $69.21M+35.4% | $51.11M+84.6% | $27.69M+51.5% | $18.27M-47.7% | ||
| $22.59M— | —— | $7.83M+34.6% | $5.82M-33.5% | $8.74M— | ||
| $29.98M— | —— | $31.14M-75.3% | $126.02M0.0% | $126.02M— | ||
| $9.67M— | —— | $10.25M+269% | $2.78M-11.8% | $3.15M— | ||
| $377.3M+8.5% | $347.63M-7.9% | $377.46M+178% | $135.55M+3.2% | $131.37M+9.9% | ||
| $478.89M— | —— | $498.98M+248% | $143.43M-2.0% | $146.36M— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 23M+0.9% | 22.8M+0.6% | 22.7M+2.2% | 22.2M+0.2% | 22.2M+0.8% | ||
| 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | ||
| 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | ||
| 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | 2.4M0.0% | ||
| $2.73B+1.3% | $2.69B+1.3% | $2.66B+1.7% | $2.61B+1.0% | $2.59B+1.2% | ||
| $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 716.1K— | —— | 789.4K-33.5% | 1.2M+3.1% | 1.2M— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 1M+3.9% | 979.9K-10.1% | 1.1M-28.8% | 1.5M+0.4% | 1.5M-0.1% | ||
| $377.1M— | —— | $243.4M-1.6% | $247.4M+1.9% | $242.7M— | ||
| $155K-82.4% | $879K+37.8% | $638K+136% | $270K-37.9% | $435K-30.4% | ||
| $401K+1,905% | $20K-89.0% | $181K+79.2% | $101K+29.5% | $78K-50.3% | ||
| $189.98+22.4% | $155.25+6.2% | $146.17+28.4% | $113.86+3.5% | $110.04+17.6% | ||
| $36.86M+37.0% | $26.91M— | —— | —— | —— | ||
| $46.83M+17.0% | $40.03M— | —— | —— | —— | ||
| $0— | $0— | —— | —— | —— | ||
| $401K+1,905% | $20K-89.0% | $181K+79.2% | $101K+29.5% | $78K-50.3% | ||
| $155K-82.4% | $879K+37.8% | $638K+136% | $270K-37.9% | $435K-30.4% | ||
| $818.17M-17.2% | $987.79M— | —— | —— | —— | ||
| $817.93M-17.3% | $988.65M— | —— | —— | —— | ||
| 2.3M— | —— | —— | —— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | ||
| $23.04M+0.9% | $22.84M+0.6% | $22.7M+2.2% | $22.22M+0.2% | $22.19M+0.8% | ||
| $23.04M+0.9% | $22.84M+0.6% | $22.7M+2.2% | $22.22M+0.2% | $22.19M+0.8% | ||
| $478.89M— | —— | $498.98M+248% | $143.43M-2.0% | $146.36M— | ||
| $9.67M— | —— | $10.25M+269% | $2.78M-11.8% | $3.15M— | ||
| $377.1M— | —— | $243.4M-1.6% | $247.4M+1.9% | $242.7M— | ||
| $143.56M+44.5% | $99.34M+10.8% | $89.68M+71.3% | $52.34M+38.2% | $37.86M+46.2% | ||
| $30.07M— | —— | $31.06M-75.4% | $126.02M0.0% | $126.02M— | ||
| $29.98M— | —— | $31.14M— | —— | —— | ||
| $366.27M— | —— | $31.06M— | —— | —— | ||
| $29.98M— | —— | $31.06M+168% | $11.6M0.0% | $11.6M— | ||
| $22.59M— | —— | $7.83M+34.6% | $5.82M-33.5% | $8.74M— | ||
| —— | —— | —— | —— | —— | ||
| $36.99M+9.6% | $33.74M+61.2% | $20.94M+90.9% | $10.97M-16.3% | $13.11M+60.5% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | ||
| $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | ||
| $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | $2.37M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $222.9M— | —— | $187.6M+163% | $71.2M-20.1% | $89.1M— | ||
| $120.75M+33.4% | $90.5M— | —— | —— | —— | ||
| 4— | —— | —— | —— | —— | ||
| 4— | —— | —— | —— | —— | ||
| $716.13K— | —— | $789.36K-33.5% | $1.19M+3.1% | $1.15M— | ||
| $1.02M+3.9% | $979.86K-10.1% | $1.09M-28.8% | $1.53M+0.4% | $1.53M-0.1% | ||
| $189.98+22.4% | $155.25+6.2% | $146.17+28.4% | $113.86+3.5% | $110.04+17.6% | ||
| $126.5— | —— | $107.68+32.6% | $81.2+3.5% | $78.44— | ||
| $9.9M— | —— | —— | —— | —— | ||
| $222.9M— | —— | $187.6M+163% | $71.2M-20.1% | $89.1M— | ||
| $22.59M— | —— | $7.83M+34.6% | $5.82M-33.5% | $8.74M— | ||
| $9.9M— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Madrigal Pharmaceuticals, Inc.'s total assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) holds $1.2B in total assets, up 23.2% year over year.
- How much debt does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. carries $377.3M in total debt against $543.5M of shareholders' equity, a debt-to-equity ratio of 0.69.
- How much cash does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. holds $232.2M in cash and equivalents.
- Can Madrigal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.50 — current assets exceed current liabilities.
- Where does Madrigal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
